Summary & Overview
CPT 66183: Anterior Chamber Glaucoma Device Insertion
CPT code 66183 captures a minimally invasive glaucoma surgical procedure in which a small device is inserted into the anterior chamber to lower intraocular pressure. This code is relevant nationally as MIGS procedures have expanded treatment options for glaucoma, affecting surgical workflows, device utilization, and payer coverage policies across outpatient settings. The procedure is typically performed in ambulatory surgery centers and hospital outpatient departments and is part of the growing shift toward less invasive glaucoma care.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, expected sites of service, and the operational implications of billing this surgical implant code. The publication summarizes common modifiers reported with this service and outlines where to find related policy language and coverage considerations.
The article provides benchmarks and policy summaries useful for coding managers, surgical practices, and revenue cycle teams: clinical definition and procedural context are described; payer coverage patterns and coding nuances are summarized; and implications for outpatient surgical scheduling and device inventory are highlighted. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 66183 describes the insertion of a small device into the anterior chamber of the eye to reduce intraocular pressure in patients with glaucoma. This procedure is a minimally invasive glaucoma surgery (MIGS) technique intended to lower intraocular pressure by implanting a device that improves aqueous outflow.
-
Service type: Surgical implant procedure for glaucoma management
-
Typical site of service: Ambulatory surgery center or hospital outpatient department
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with primary open-angle glaucoma presents with progressively elevated intraocular pressure (IOP) despite maximally tolerated topical therapy. After assessment in the ophthalmology clinic, including slit-lamp exam, gonioscopy, and visual field testing, the surgeon plans an ab interno micro-invasive glaucoma surgery (MIGS) procedure to implant an intraocular pressure–lowering device into the anterior chamber. The typical workflow: preoperative evaluation and informed consent in clinic; same-day surgery in an ambulatory surgery center or hospital outpatient department under local anesthesia with monitored sedation; creation of a small clear corneal incision; placement of the microstent/device into the angle/anterior chamber to improve aqueous outflow; intraoperative confirmation of device position and hemostasis; brief postoperative recovery with IOP monitoring; and follow-up visits at 1 day, 1 week, and 1 month to assess IOP, the anterior chamber, and visual function. Typical sites of service are the ambulatory surgery center or hospital outpatient department. The typical service type is an ophthalmic surgical implant procedure for glaucoma management. Common patient scenario: single-eye implantation for uncontrolled glaucoma, often combined with cataract surgery when appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician's professional component separate from the facility or technical component, if applicable for diagnostic imaging or interpretation associated with the procedure. |